-
Product Insights
NewLikelihood of Approval Analysis for Niemann-Pick Disease
Overview How likely is it that the drugs in Niemann-Pick Disease will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Niemann-Pick Disease Overview Acid sphingomyelinase deficiency (ASMD) is a rare genetic disorder...
-
Product Insights
Net Present Value Model: Xenpozyme
Overview Evaluating the value of drugs is a complicated practice and requires a deep knowledge of the drug itself, the market currently and in the future, knowledge of cash inflows and outflows and the potential success rates for each stage of drug development. GlobalData has done all of this work for you, leveraging its gold standard Drugs Intelligence database to create high-value NPV models for purchase on a drug-by-drug basis. Drug Operating Profit Model Xenpozyme Drug Details Olipudase alfa (Xenpozyme)...